Pesquisa | BVS IEC

1.

A promising step for high-risk FL.

Hübel, Kai.

Blood ; 143(17): 1679-1681, 2024 Apr 25.

Artigo em Inglês | MEDLINE | ID: mdl-38662385

2.

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.

Cooper, Jason P; Storer, Barry E; Granot, Noa; Gyurkocza, Boglark; Sorror, Mohamed L; Chauncey, Thomas R; Shizuru, Judith; Franke, Georg-Nikolaus; Maris, Michael B; Boyer, Michael; Bruno, Benedetto; Sahebi, Firoozeh; Langston, Amelia A; Hari, Parameswaran; Agura, Edward D; Lykke Petersen, Søren; Maziarz, Richard T; Bethge, Wolfgang; Asch, Julie; Gutman, Jonathan A; Olesen, Gitte; Yeager, Andrew M; Hübel, Kai; Hogan, William J; Maloney, David G; Mielcarek, Marco; Martin, Paul J; Flowers, Mary E D; Georges, George E; Woolfrey, Ann E; Deeg, Joachim H; Scott, Bart L; McDonald, George B; Storb, Rainer; Sandmaier, Brenda M.

Haematologica ; 106(6): 1599-1607, 2021 06 01.

Artigo em Inglês | MEDLINE | ID: mdl-32499241

3.

The Changing Landscape of Lymphoma Associated with HIV Infection.

Hübel, Kai.

Curr Oncol Rep ; 22(11): 111, 2020 08 15.

Artigo em Inglês | MEDLINE | ID: mdl-32803474

4.

Malignant lymphoma in the HIV-positive patient.

Meister, Anne; Hentrich, Marcus; Wyen, Christoph; Hübel, Kai.

Eur J Haematol ; 101(1): 119-126, 2018 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-29663523

5.

Correction to: The Changing Landscape of Lymphoma Associated with HIV Infection.

Hübel, Kai.

Curr Oncol Rep ; 23(10): 121, 2021 Aug 09.

Artigo em Inglês | MEDLINE | ID: mdl-34370105

6.

Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma.

Belada, David; Georgiev, Pencho; Dakhil, Shaker; Inhorn, Lowell F; Andorsky, David; Beck, J Thaddeus; Quick, Donald; Pettengell, Ruth; Daly, Robert; Dean, James P; Pavlyuk, Mariya; Failloux, Nelly; Hübel, Kai.

Future Oncol ; 12(15): 1759-68, 2016 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-27093976

7.

Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective.

Hübel, Kai; de la Rubia, Javier; Azar, Nabih; Corradini, Paolo.

Eur J Haematol ; 94(1): 12-22, 2015 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-24797118

8.

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.

Hartmann, Tim; Hübel, Kai; Monsef, Ina; Engert, Andreas; Skoetz, Nicole.

Cochrane Database Syst Rev ; (10): CD010615, 2015 Oct 20.

Artigo em Inglês | MEDLINE | ID: mdl-26484982

9.

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.

Kornblit, Brian; Maloney, David G; Storer, Barry E; Maris, Michael B; Vindeløv, Lars; Hari, Parameswaran; Langston, Amelia A; Pulsipher, Michael A; Bethge, Wolfgang A; Chauncey, Thomas R; Lange, Thoralf; Petersen, Finn B; Hübel, Kai; Woolfrey, Ann E; Flowers, Mary E D; Storb, Rainer; Sandmaier, Brenda M.

Haematologica ; 99(10): 1624-31, 2014 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-25085357

10.

Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) FL with CAR-T Cell Therapy: A Vodcast and Case Example.

Hübel, Kai.

Oncol Ther ; 2024 Mar 21.

Artigo em Inglês | MEDLINE | ID: mdl-38512599

11.

Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial.

Hoster, Eva; Delfau-Larue, Marie-Hélène; Macintyre, Elizabeth; Jiang, Linmiao; Stilgenbauer, Stephan; Vehling-Kaiser, Ursula; Salles, Gilles; Thieblemont, Catherine; Tilly, Hervé; Wirths, Stefan; Feugier, Pierre; Hübel, Kai; Schmidt, Christian; Ribrag, Vincent; Kluin-Nelemans, Johanna C; Dreyling, Martin; Pott, Christiane.

J Clin Oncol ; 42(5): 538-549, 2024 Feb 10.

Artigo em Inglês | MEDLINE | ID: mdl-37992261

12.

Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC).

Niederwieser, Christian; Iacobelli, Simona; Franke, Georg-Nikolaus; Koster, Linda; van Os, Marleen; Platzbecker, Uwe; Hübel, Kai; Scheid, Christof; Müller, Lutz Peter; Stelljes, Matthias; Morozova, Elena; Passweg, Jakob; Onida, Francesco; Dreger, Peter; Saccardi, Riccardo; Ladetto, Marco; Salmenniemi, Urpu; Bethge, Wolfgang; Poiré, Xavier; Kobbe, Guido; McLornan, Donal P; Robin, Marie; Kröger, Nicolaus.

Bone Marrow Transplant ; 2024 Apr 25.

Artigo em Inglês | MEDLINE | ID: mdl-38664589

13.

Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial.

Kornblit, Brian; Maloney, David G; Storb, Rainer; Storek, Jan; Hari, Parameswaran; Vucinic, Vladan; Maziarz, Richard T; Chauncey, Thomas R; Pulsipher, Michael A; Bruno, Benedetto; Petersen, Finn B; Bethge, Wolfgang A; Hübel, Kai; Bouvier, Michelle E; Fukuda, Takahiro; Storer, Barry E; Sandmaier, Brenda M.

Biol Blood Marrow Transplant ; 19(9): 1340-7, 2013 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-23769990

14.

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy.

Straka, Christian; Sandherr, Michael; Salwender, Hans; Wandt, Hannes; Metzner, Bernd; Hübel, Kai; Silling, Gerda; Hentrich, Marcus; Franke, Daniel; Schwerdtfeger, Rainer; Freund, Mathias; Sezer, Orhan; Giagounidis, Alexander; Ehninger, Gerhard; Grimminger, Wolfgang; Engert, Andreas; Schlimok, Günter; Scheid, Christof; Hellmann, Peter; Heinisch, Harald; Einsele, Hermann; Hinke, Axel; Emmerich, Bertold.

Blood ; 117(7): 2121-8, 2011 Feb 17.

Artigo em Inglês | MEDLINE | ID: mdl-21163927

15.

High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.

Hermine, Olivier; Jiang, Linmiao; Walewski, Jan; Bosly, André; Thieblemont, Catherine; Szymczyk, Michal; Pott, Christiane; Salles, Gilles; Feugier, Pierre; Hübel, Kai; Haioun, Corinne; Casasnovas, René Olivier; Schmidt, Christian; Bouabdallah, Kamal; Ribrag, Vincent; Kanz, Lothar; Dürig, Jan; Metzner, Bernd; Sibon, David; Cheminant, Morgane; Burroni, Barbara; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva; Dreyling, Martin.

J Clin Oncol ; 41(3): 479-484, 2023 01 20.

Artigo em Inglês | MEDLINE | ID: mdl-36469833

16.

Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide.

Malard, Florent; Kröger, Nicolaus; Gabriel, Ian H; Hübel, Kai; Apperley, Jane F; Basak, Grzegorz W; Douglas, Kenneth W; Geraldes, Catarina; Jaksic, Ozren; Koristek, Zdenek; Lanza, Francesco; Lemoli, Roberto; Mikala, Gabor; Selleslag, Dominik; Worel, Nina; Mohty, Mohamad; Duarte, Rafael F.

Biol Blood Marrow Transplant ; 18(2): 314-7, 2012 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-22001752

17.

European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization.

Worel, Nina; Apperley, Jane F; Basak, Grzegorz W; Douglas, Kenneth W; Gabriel, Ian H; Geraldes, Catarina; Hübel, Kai; Jaksic, Ozren; Koristek, Zdenek; Lanza, Francesco; Lemoli, Roberto; Mikala, Gabor; Selleslag, Dominik; Duarte, Rafael F; Mohty, Mohamad.

Transfusion ; 52(11): 2395-400, 2012 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-22414093

18.

Lymphoma: New Diagnosis and Current Treatment Strategies.

Hübel, Kai.

J Clin Med ; 11(6)2022 Mar 19.

Artigo em Inglês | MEDLINE | ID: mdl-35330026

19.

Recent Advances in Castleman Disease.

Hoffmann, Christian; Hentrich, Marcus; Tiemann, Markus; Rosenwald, Andreas; Weber, Florian; Willenbacher, Wolfgang; Hübel, Kai.

Oncol Res Treat ; 45(11): 693-704, 2022.

Artigo em Inglês | MEDLINE | ID: mdl-36219975

20.

Reduced-intensity conditioning in allogeneic stem cell transplantation for hematological malignancies: a historical perspective.

Cremer, Birgit; Sandmaier, Brenda M; Bethge, Wolfgang; Lange, Thoralf; Goede, Valentin; Holtick, Udo; Hallek, Michael; Hübel, Kai.

Onkologie ; 34(12): 710-5, 2011.

Artigo em Inglês | MEDLINE | ID: mdl-22156452

BVS IEC

Instituto Evandro Chagas

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

A promising step for high-risk FL.

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.

The Changing Landscape of Lymphoma Associated with HIV Infection.

Malignant lymphoma in the HIV-positive patient.

Correction to: The Changing Landscape of Lymphoma Associated with HIV Infection.

Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma.

Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective.

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.

Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) FL with CAR-T Cell Therapy: A Vodcast and Case Example.

Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial.

Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC).

Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial.

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy.

High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.

Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide.

European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization.

Lymphoma: New Diagnosis and Current Treatment Strategies.

Recent Advances in Castleman Disease.

Reduced-intensity conditioning in allogeneic stem cell transplantation for hematological malignancies: a historical perspective.